

Chloroquine phosphate (CAS 50-63-5) remains a cornerstone of the US API intermediates market, where high purity fine chemicals with Pharma/API purity 99% are mandated for the formulation of antimalarial treatments and the management of autoimmune conditions like systemic lupus erythematosus. 1,4-Pentanediamine, N4-(7-chloro-4-quinolinyl)-N1,N1-diethyl-, phosphate (1:2) is increasingly sourced by domestic CDMOs through custom synthesis services to ensure supply chain resilience and compliance with stringent FDA and USP monographs, effectively mitigating risks from global sourcing shifts. Chloroquine diphosphate also maintains a significant footprint in the general industry purity 98% segment for specialized research and industrial applications, driving the need for a reliable bulk chemical supplier capable of providing high-depth technical documentation and navigating the complex regulatory landscape of the United States. We are an established Chloroquine Phosphate api supplier with >= 99% purity for semi-finished formulators in the united states , providing comprehensive analytical (HPLC/NMR/MS) and supporting (Chloroquine Phosphate) COA/TDS/SDS region-specific regulatory support. reliable lead times, worldwide supply chain capabilities


Chloroquine phosphate (CAS 50-63-5) remains a cornerstone of the US API intermediates market, where high purity fine chemicals with Pharma/API purity 99% are mandated for the formulation of antimalarial treatments and the management of autoimmune conditions like systemic lupus erythematosus. 1,4-Pentanediamine, N4-(7-chloro-4-quinolinyl)-N1,N1-diethyl-, phosphate (1:2) is increasingly sourced by domestic CDMOs through custom synthesis services to ensure supply chain resilience and compliance with stringent FDA and USP monographs, effectively mitigating risks from global sourcing shifts. Chloroquine diphosphate also maintains a significant footprint in the general industry purity 98% segment ...
Pharmaceutical
Pharmaceutical Actives & Precursors
Active Pharmaceutical Ingredients (APIs)
.7767eb0f.png)

Chemical Properties & Specifications
P203, P260, P264, P270, P280, P301+P317, P318, P319, P330, P405, and P501
Acute Tox. 4 (98.7%)
Repr. 1A (32.5%)
A 4-aminoquinoline compound used for the prophylaxis and treatment of uncomplicated malaria caused by susceptible strains of Plasmodium vivax, P. malariae, P. ovale, and P. falciparum
A therapeutic agent indicated for the treatment of extraintestinal amebiasis, specifically amoebic liver abscesses
A disease-modifying medication utilized off-label to manage symptoms of autoimmune disorders such as rheumatoid arthritis and systemic or discoid lupus erythematosus
A biochemical tool used in scientific research for in vitro experiments to inhibit lysosomal degradation and investigate viral replication mechanisms.
Chloroquine Phosphate is an antimalarial and amebicidal drug used to prevent and treat malaria, as well as treat extraintestinal amebiasis and certain autoimmune conditions like rheumatoid arthritis and lupus erythematosus
This compound is primarily used in the pharmaceutical and healthcare industries for the production of antimalarial, anti-inflammatory, and specialized research medications
It is freely soluble in water and is typically formulated as oral tablets, although injectable solutions and oral suspensions are also used
Standard specifications include CAS number 50-63-5, a molecular weight of 515.86, high purity (typically ≥98%), and documentation such as COA, TDS, impurity reports, and regulatory compliance documents
Scimplify has capabilities for global distribution and custom synthesis through an integrated network of manufacturers and logistics partners with reliable lead time
The product is export ready with a standard MOQ starting from 100 kgs, with lead times for international customers depending on the shipping destination and specific grade.
Category : Pharmaceutical Actives & Precursors
Sub-Category : Intermediates & Precursors
Description : P-Nitrobenzoyl Chloride (CAS 122-04-3) is a critical building block in the API intermediates market,...